Animal models of neurodegenerative diseases;Modèles animaux des maladies neuro- dégénératives

Medecine/Sciences

Volumn 23, Issue 2, 2007, Pages 180-186

  Langui, Dominique ^a   Lachapelle, François ^a   Duyckaerts, Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMYLOID PROTEIN; REELIN; TAU PROTEIN;

AGYRIA; ALZHEIMER DISEASE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN NERVE CELL; CAENORHABDITIS ELEGANS; CLINICAL FEATURE; DEGENERATIVE DISEASE; DROSOPHILA; FRONTOTEMPORAL DEMENTIA; GENE IDENTIFICATION; GENE MUTATION; HUNTINGTON CHOREA; IDIOPATHIC DISEASE; MULTIPLE PREGNANCY; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; REVIEW; SCREENING TEST; SPINOCEREBELLAR DEGENERATION; SUBSTANTIA NIGRA; TOPOGRAPHY;

ANIMALIA; CAENORHABDITIS ELEGANS; MUS MUSCULUS;

EID: 33847149186     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2007232180     Document Type: Review

References (54)

1. De la Torre JC, Fortin T. A chronic physiological rat model of dementia. Behav Brain Res 1994 ; 63 : 35-40.
2. Spencer PS, Nunn PB, Hugon J, et al. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 1987 ; 237 : 517-22.
3. Caparros-Lefebvre D, Sergeant N, Lees A, et al. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain 2002 ; 125 : 801-11.
4. Langston JW, Bollard P, Tetrud J, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983 ; 219 : 979-80.
5. D'Arcangelo G, G. Miao G, Chen SC, et al. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995 ; 374 : 719-23.
6. Hong SE, Shugart YY, Huang DT, et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet 2000 ; 26 : 93-6.
7. Impagnatiello F, Guidotti AR, Pesold C, et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 1998 ; 95 : 15718-23.
8. Lane PW. New mutation: weaver, wv. Mouse News Lett 1964 ; 30 : 32-3.
9. Schmidt MJ, Sawyer BD, Perry KW, et al. Dopamine deficiency in the weaver mutant mouse. J Neurosci 1982 ; 2 : 376-80.
10. Rezai Z, Yoon CH. Abnormal rate of granule cell migration in the cerebellum of weaver mutant mice. Dev Biol 1972 ; 29 : 17-26.
11. Rakic P, Sidman RL. Organization of cerebellar cortex secondary to deficit of granule cells in weaver mutant mice. J Comp Neurol 1973 ; 152 : 133-61.
12. Patil N, Cox DR, Bhat D, et al. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat Genet 1995 ; 11 : 126-9.
13. Bandmann O, Davis MB, Mrasden CD, Wood NW. The human homologue of the weaver mouse gene in familial and sporadic Parkinson's disease. Neuroscience 1996 ; 72 : 877-9.
14. Gold DA, Baek SH, Schork NJ, et al. RORα coordinates reciprocal signaling in cerebellar development through sonic hedgehog and calcium-dependent pathways. Neuron 2003 ; 40 : 1119-31.
15. Blanchard V, Moussaoui S, Czech C, et al. Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Exp Neurol 2003 ; 184 : 247-63.
16. Schmitz C, Rutten BP, Pielen A, et al. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am J Pathol 2004 ; 164 : 1495-502.
17. Langui D, Girardot N, El Hachimi H, et al. Subcellular topography of neuronal Aβ peptide in APPxPS1 transgenic mice. Am J Pathol 2004 ; 165 : 1465-77.
18. Robbins EM, Betensky RA, Domnitz SB, et al. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease, J Neurosci. 2006 ; 26 : 365-71.
19. Götz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science 2001 ; 293 : 1491-5.
20. Ghetti B, Hutton ML, Wszolek ZK. Fronto-temporal dementia and parkinsonism linked to chromosome 17 associated with Tau gene mutations (FTDP-17T). In : Dickson D, ed. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel : ISN Neuropath Press, 2003 : 86-102.
21. Probst A, Gotz J, Wiederhold KH, et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (Berl) 2000 ; 99 : 469-81.
22. Spittaels K, Van den Haute C, Van Dorpe J, et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 1999 ; 155 : 2153-65.
23. Brion JP, Tremp G, Octave JN. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am J Pathol 1999 ; 154 : 255-70.
24. Behar L, Marx R, Sadot E, et al. Cis-acting signals and trans-acting proteins are involved in tau mRNA targeting into neurites of differentiating neuronal cells. Int J Dev Neurosci 1995 ; 13 : 113-27.
25. Andorfer C, Acker CM, Kress Y, et al. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci 2005 ; 25 : 5446-54.
26. SantaCruz K, Lewis J, Spires T, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005 ; 309 : 476-81.
27. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997 ; 276 : 2045-7.
28. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 1998 ; 18 : 106-8.
29. Kahle PJ, Neumann M, Ozmen L, et al. Subcellular localization of wild-type and Parkinson's disease-associated mutant α-synuclein in human and transgenic mouse brain. J Neurosci 2000 ; 20 : 6365-73.
30. Masliah E, Rockenstein E, Veinbergs I, et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 2000 ; 287 : 1265-9.
31. Giasson BI, Duda JE, Quinn SM, et al. Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein. Neuron 2002 ; 34 : 521-33.
32. Fleming SM, Salcedo J, Fernagut PO, et al. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein. J Neurosci 2004 ; 24 : 9434-40.
33. Masliah E, Rockenstein E, Veinbergs I, et al. β-amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci USA 2001 ; 98 : 12245-50.
34. Schmidt ML, Martin JA, Lee VM, Trojanowski JQ. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol 1996 ; 91 : 475-81.
35. Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983 ; 306 : 234-8.
36. The Huntington's disease collaborative research group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993 ; 72 : 971-83.
37. Davies SW, Turmaine M, Cozens BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997 ; 90 : 537-48.
38. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997 ; 277 : 1990-3.
39. Van Dellen A, Blakemore C, Deacon R, et al. Delaying the onset of Huntington's in mice. Nature 2000 ; 404 : 721-2.
40. Koeppen AH. The hereditary ataxias. J Neuropathol Exp Neurol 1998 ; 57 : 531-43.
41. Yvert G, Lindenberg K, Picaud S, et al. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice. Hum Mol Genet 2000 ; 9 : 2491-506.
42. Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998 ; 95 : 55-66.
43. Everett C, Wood N. Trinucleotide repeats and neurodegenerative disease. Brain 2004 ; 127 : 2385-405.
44. Periquet M, Corti O, Jacquier S, Brice A. Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synoptic function. J Neurochem 2005 ; 95 : 1259-76.
45. Simon D, Seznec H, Gansmuller A, et al. Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J Neurosci 2004 ; 24 : 1987-95.
46. Puccio H, Simon D, Cossee M, et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001 ; 27 : 181-6.
47. Ristow M, Mulder H, Pomplun D, et al. Frataxin deficiency in pancreatic islets causes diabetes due to loss of β cell mass. J Clin Invest 2003 ; 112 : 527-34.
48. Prusiner SB. Molecular biology and pathogenesis of prion diseases. Trends Biochem Sci 1996 ; 21 : 482-7.
49. Basler K, Oesch B, Scott M, et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986 ; 46 : 417-28.
50. Bueler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993 ; 73 : 1339-47.
51. Telling GC, Scott M, Hsiao KK, et al. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci USA 1994 ; 91 : 9936-40.
52. Feany MB, Bender WW. A drosophila model of Parkinson's disease. Nature 2000 ; 404 : 394-8.
53. Holbert S, Denghien I, Kiechle T, et al. The Gin-Ala repeat transcriptional activator CA150 interacts with Huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci USA 2001 ; 98 : 1811-6.
54. Parker JA, Arango M, Abderrahmane S, et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 2005 ; 37 : 349-50.